INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes

ClinicalTrials.gov ID: NCT07224321

Public ClinicalTrials.gov record NCT07224321. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 6, 2026, 8:57 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

INHALE-1st: Technosphere Insulin (Afrezza®) In Combination With Basal Insulin For Youth With Newly-Diagnosed Type 1 Diabetes

Study identification

NCT ID: NCT07224321
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: Mannkind Corporation; Industry
Enrollment: 100 participants

Conditions and interventions

Conditions

Type 1 Diabetes Mellitus

Interventions

Basal insulin Drug
Technosphere Insulin Drug

Drug

Eligibility (public fields only)

Age range: 10 Years to 17 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Feb 3, 2026
Primary completion: Feb 28, 2027
Completion: Aug 31, 2027
Last update posted: May 4, 2026

2026 – 2027

United States locations

U.S. sites: 10
U.S. states: 9
U.S. cities: 10

Facility	City	State	ZIP	Site status
Children's Hospital Los Angeles	Los Angeles	California	90027	Not yet recruiting
University of California San Francisco	San Francisco	California	94158	Not yet recruiting
Barbara Davis Center for Diabetes Young Adult Clinic	Aurora	Colorado	80045	Recruiting
Yale University	New Haven	Connecticut	06511	Not yet recruiting
University of Florida	Gainesville	Florida	32610	Not yet recruiting
Indiana University	Indianapolis	Indiana	46202	Not yet recruiting
Joslin Diabetes Center	Boston	Massachusetts	02215	Recruiting
University of Oklahoma Health Sciences Center	Oklahoma City	Oklahoma	73104	Not yet recruiting
Baylor College of Medicine	Houston	Texas	77030	Not yet recruiting
University of Virginia	Charlottesville	Virginia	22903	Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07224321, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted May 4, 2026 · Synced May 6, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07224321 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →